Federal Register - March 17, 2021

Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.

Source: Federal Register

14578

Federal Register / Vol. 86, No. 50 / Wednesday, March 17, 2021 / Notices
be accessed through the following link Webex: https bit.ly/NVSAC51921.
FOR FURTHER INFORMATION CONTACT: Ana Victoria Fortes, Designated Federal Officer DFO at afortes@usccr.gov or by phone at 202 6810857.
SUPPLEMENTARY INFORMATION: This meeting is available to the public through the following toll-free call-in number: 8003609505; Access code:
199 070 2234. Any interested member of the public may call this number and listen to the meeting. Callers can expect to incur charges for calls they initiate over wireless lines, and the Commission will not refund any incurred charges.
Callers will incur no charge for calls they initiate over land-line connections to the toll-free telephone number.
Persons with hearing impairments may also follow the proceedings by first calling the Federal Relay Service at 1
8008778339 and providing the Service with the conference call number and conference ID number.
Members of the public are entitled to make comments during the open period at the end of the meeting. Members of the public may also submit written comments; the comments must be received in the Regional Programs Unit within 30 days following the meeting.
Written comments may be mailed to the Western Regional Office, U.S.
Commission on Civil Rights, 300 North Los Angeles Street, Suite 2010, Los Angeles, CA 90012 or email Ana Victoria Fortes at afortes@usccr.gov.
Records and documents discussed during the meeting will be available for public viewing prior to and after the meeting at https
www.facadatabase.gov/FACA/
FACAPublicViewCommitteeDetails ?id=a10t0000001gzlJAAQ.
Please click on the Committee Meetings tab. Records generated from these meetings may also be inspected and reproduced at the Regional Programs Unit, as they become available, both before and after the meetings. Persons interested in the work of this Committee are directed to the Commissions website, https
www.usccr.gov, or may contact the Regional Programs Unit at the above email or street address.

jbell on DSKJLSW7X2PROD with NOTICES

Agenda Opening Remarks 12:0012:15 p.m.
Speaker Presentations 12:151:15 p.m.
Erin Phillips, President, Power2Parent Representative, Nevada COVID19
Response, Relief and Recovery Taskforce Rebecca Garcia, President, Nevada Parent Teacher Association
VerDate Sep<11>2014

17:47 Mar 16, 2021

Jkt 253001

Q & A 1:152:10 p.m.
Public Comment 2:102:25 p.m.
Closing Remarks 2:252:30 p.m.
Dated: March 11, 2021.
David Mussatt, Supervisory Chief, Regional Programs Unit.
FR Doc. 202105471 Filed 31621; 8:45 am BILLING CODE P

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board B202021

Foreign-Trade Zone FTZ 177
Evansville, Indiana; Notification of Proposed Production Activity;
AstraZeneca Pharmaceuticals LP
Pharmaceutical Products; Mount Vernon, Indiana AstraZeneca Pharmaceuticals LP
AstraZeneca submitted a notification of proposed production activity to the FTZ Board for its facility in Mount Vernon, Indiana. The notification conforming to the requirements of the regulations of the FTZ Board 15 CFR
400.22 was received on March 9, 2021.
AstraZeneca already has authority to produce certain pharmaceuticals products within Subzone 177A. The current request would add finished products and foreign status materials to the scope of authority. Pursuant to 15
CFR 400.14b, additional FTZ authority would be limited to the specific foreignstatus materials and specific finished products described in the submitted notification as described below and subsequently authorized by the FTZ
Board.
Production under FTZ procedures could exempt AstraZeneca from customs duty payments on the foreignstatus materials/components used in export production. On its domestic sales, for the foreign-status materials/
components noted below and in the existing scope of authority, AstraZeneca would be able to choose the duty rates during customs entry procedures that apply to: CALQUENCE acalabrutinib capsules; DAKLINZA daclatasvir tablets; FARXIGAFORXIGA
dapagliflozin tablets; KOMBIGLYZE IR
metformin hydrochloride and saxagliptin hydrochloride tablets;
KOMBIGLYZE XR metformin hydrochloride and saxagliptin hydrochloride tablets; METFORMIN IR
metformin hydrochloride tablets;
ONGLYZA saxagliptin hydrochloride tablets; QTERN dapagliflozin and saxagliptin hydrochloride tablets;
QTERNMET XR dapagliflozin, metformin hydrochloride and
PO 00000

Frm 00008

Fmt 4703

Sfmt 4703

saxagliptin hydrochloride tablets;
TAGRISSO osimertinib mesylate tablets; XIGDUO IR dapagliflozin and metformin hydrochloride tablets; and, XIGDUO XR dapagliflozin and metformin hydrochloride tablets dutyfree. AstraZeneca would be able to avoid duty on foreign-status components which become scrap/waste.
Customs duties also could possibly be deferred or reduced on foreign-status production equipment.
The materials sourced from abroad include: Metformin hydrochloride active pharmaceutical ingredient API;
dapagliflozin API; daclatasvir API;
osimertinib mesylate API; acalabrutinib API; and, saxagliptin hydrochloride API
duty rate ranges from 3.7% to 6.5%.
The request indicates that certain materials are subject to duties under Section 301 of the Trade Act of 1974
Section 301, depending on the country of origin. The applicable Section 301
decisions require subject merchandise to be admitted to FTZs in privileged foreign status 19 CFR 146.41.
Public comment is invited from interested parties. Submissions shall be addressed to the Boards Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is April 26, 2021.
A copy of the notification will be available for public inspection in the Reading Room section of the Boards website, which is accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov.
Dated: March 11, 2021.
Andrew McGilvray, Executive Secretary.
FR Doc. 202105478 Filed 31621; 8:45 am BILLING CODE 3510DSP

DEPARTMENT OF COMMERCE
International Trade Administration C351846

Certain Hot-Rolled Steel Flat Products From Brazil: Rescission of the 2019
Countervailing Duty Administrative Review Enforcement and Compliance, International Trade Administration, Department of Commerce.
SUMMARY: The Department of Commerce Commerce is rescinding the administrative review of the countervailing duty CVD order on certain hot-rolled steel flat products hot-rolled steel from Brazil for the AGENCY:

E:FRFM17MRN1.SGM

17MRN1

Riguardo a questa edizione

Federal Register - March 17, 2021

TitoloFederal Register

PaeseStati Uniti

Data17/03/2021

Conteggio pagine173

Numero di edizioni7802

Prima edizione14/03/1936

Ultima edizione25/06/2026

Scarica questa edizione

Altre edizioni

<<<Marzo 2021>>>
DLMMJVS
123456
78910111213
14151617181920
21222324252627
28293031